Camp4 Therapeutics Corp Net Income (Loss) Attributable to Parent in USD from Q1 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Camp4 Therapeutics Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2023 to Q3 2025.
  • Camp4 Therapeutics Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$15.1M, a 12% decline year-over-year.
  • Camp4 Therapeutics Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$53.4M, a 3.68% decline year-over-year.
  • Camp4 Therapeutics Corp annual Net Income (Loss) Attributable to Parent for 2024 was -$51.8M, a 5.07% decline from 2023.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

Camp4 Therapeutics Corp Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$53.4M -$15.1M -$1.62M -12% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 -$51.8M -$12.6M -$15K -0.12% Apr 1, 2025 Jun 30, 2025 10-Q 2025-11-06
Q1 2025 -$51.8M -$12.4M +$23K +0.19% Jan 1, 2025 Mar 31, 2025 10-Q 2025-11-06
Q4 2024 -$51.8M -$13.3M -$290K -2.23% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-27
Q3 2024 -$51.5M -$13.5M -$1.79M -15.3% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 -$49.7M -$12.6M -$472K -3.9% Apr 1, 2024 Jun 30, 2024 10-Q 2025-11-06
Q1 2024 -$49.2M -$12.5M +$50K +0.4% Jan 1, 2024 Mar 31, 2024 10-Q 2025-11-06
Q4 2023 -$49.3M -$13M Oct 1, 2023 Dec 31, 2023 10-K 2025-03-27
Q3 2023 -$11.7M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-21
Q2 2023 -$12.1M Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-21
Q1 2023 -$12.5M Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-21

Camp4 Therapeutics Corp Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$51.8M -$2.5M -5.07% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-27
2023 -$49.3M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.